Literature DB >> 14614072

Plasmid-borne extended-spectrum beta-lactamase in a clinical isolate of Acinetobacter baumannii.

Suresh G Joshi1, Geetanjali M Litake1, Vikram S Ghole1, Krishnarao B Niphadkar1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614072     DOI: 10.1099/0022-1317-52-12-1125

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


× No keyword cloud information.
  6 in total

1.  Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from Tertiary Care Hospital in Islamabad, Pakistan.

Authors:  Shahzeera Begum; Fariha Hasan; Shagufta Hussain; Aamer Ali Shah
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

2.  Multiple drug resistant carbapenemases producing Acinetobacter baumannii isolates harbours multiple R-plasmids.

Authors:  Rajagopalan Saranathan; Pagal Sudhakar; R Uma Karthika; Santosh Kumar Singh; P Shashikala; Reba Kanungo; K Prashanth
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

3.  Molecular Genotyping of Acinetobacter baumannii Species Isolated from Patients in Tehran, Iran, by Repetitive Element PCR Fingerprinting.

Authors:  Baharak Kian; Reza Mirnejad; Gholamali Moradli; Shiva Mirkalantari; Reza Golmohammadi
Journal:  Iran J Pathol       Date:  2018-07-17

4.  Detection and genetic characterization of extended-spectrum beta-lactamases producers in a tertiary care hospital.

Authors:  Suryarashmi Sahoo; Sarita Otta; Bichitrananda Swain; Subrat Kumar Kar
Journal:  J Lab Physicians       Date:  2019 Jul-Sep

5.  Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania.

Authors:  Stephen E Mshana; Erasmus Kamugisha; Mariam Mirambo; Trinad Chakraborty; Eligius F Lyamuya
Journal:  BMC Res Notes       Date:  2009-03-26

6.  Fight evolution with evolution: plasmid-dependent phages with a wide host range prevent the spread of antibiotic resistance.

Authors:  Ville Ojala; Jarkko Laitalainen; Matti Jalasvuori
Journal:  Evol Appl       Date:  2013-06-10       Impact factor: 5.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.